PhotoMedex to Present at 2007 FBR Growth Conference

Business Wire, May 30, 2007

MONTGOMERYVILLE, Pa. -- PhotoMedex, Inc. (Nasdaq:PHMD) today announced that Jeffrey O'Donnell, president and chief executive officer, and Dennis McGrath, chief financial officer and vice president of finance, will present at the 2007 FBR Growth Conference on Thursday, May 31, at 12:50 p.m. ET. The conference will be held at the Grand Hyatt Hotel in New York City from May 30 - May 31, 2007.

A live webcast of the presentation will be available by going to www.photomedex.com and clicking on the link to Investor Information. An archived replay will be available for a period of 30 days.

About PhotoMedex

PhotoMedex is engaged in the development of proprietary excimer laser and fiber optic systems and techniques directed toward dermatological applications, with FDA 510(k) clearances to market the XTRAC([R]) laser system for the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. In addition, the Company provides contract medical procedures to hospitals, surgi-centers and doctors' offices, offering a wide range of products and services across multiple specialty areas, including dermatology, urology, gynecology, orthopedics, and other surgical specialties. The Company is a leader in the development, manufacturing and marketing of medical laser products and services. In addition, as a result of the merger with ProCyte, PhotoMedex now develops and markets products based on its patented, clinically proven Copper Peptide technology for skin health, hair care and wound care. PhotoMedex sells directly to dermatologists, plastic and cosmetic surgeons, spas and salons and through licenses with strategic partners into the consumer market, including a long-term worldwide license agreement with Neutrogena([R]), a Johnson & Johnson company. ProCyte brands include Neova([R]), Ti-Silc([R]), VitalCopper([R]), Simple Solutions([R]) and AquaSante([R]).